Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

May 2023; Volume 43,Issue 5

Review

  • Open Access
    The Clinical Impact of the Tumor Stroma Ratio in Gastrointestinal Cancer Treatment
    TORU AOYAMA, ITARU HASHIMOTO and TAKASHI OSHIMA
    Anticancer Research May 2023, 43 (5) 1877-1883; DOI: https://doi.org/10.21873/anticanres.16346

Experimental Studies

  • Open Access
    The Novel Use of IL-28 as an Effective Radiosensitizer in Pancreatic Cancer
    XUHUI CHEN, HAYDEN Y. LEE, TRIEN T. TANG, CHENGLU QIN, SAMUEL A. PRISSEL, CHRISTIAN J. NELSON, LUKE A. SMITH, HUAPING XIAO, QIAN BAI, MICHAEL B. NICHOLL, MARK R. WAKEFIELD and YUJIANG FANG
    Anticancer Research May 2023, 43 (5) 1885-1890; DOI: https://doi.org/10.21873/anticanres.16347
  • Open Access
    Somatic Variants in DNA Damage Response Genes in Ovarian Cancer Patients Using Whole-exome Sequencing
    JOANNA LOPACINSKA-JOERGENSEN, DOUGLAS V.N.P. OLIVEIRA, TIM SVENSTRUP POULSEN, CLAUS K. HOEGDALL and ESTRID V. HOEGDALL
    Anticancer Research May 2023, 43 (5) 1891-1900; DOI: https://doi.org/10.21873/anticanres.16348
  • Open Access
    Dimethyl Fumarate Suppresses the Proliferation of HTLV-1-infected T Cells by Inhibiting CBM Complex-triggered NF-GraphicB Signaling
    TSUYOSHI SATO, TAKAHIRO MAETA and SHIGEKI ITO
    Anticancer Research May 2023, 43 (5) 1901-1908; DOI: https://doi.org/10.21873/anticanres.16349
  • Open Access
    Reinforcement of the Tumor Suppressing Properties of microRNA-1 by Substitution at the C2′ Position of Varying Ribose Residues in Chemically Synthesized microRNA-1 Molecules
    HANNES AHREND, BETTINA APPEL, LISA JUNG, SABINE MÜLLER and MATTHIAS B. STOPE
    Anticancer Research May 2023, 43 (5) 1909-1918; DOI: https://doi.org/10.21873/anticanres.16350
  • Open Access
    Pharmacokinetics and Pharmacodynamics of Glucarpidase Rescue Treatment After High-dose Methotrexate Therapy Based on Modeling and Simulation
    TOSHIMI KIMURA, YUTAKA FUKAYA, YUKIHIRO HAMADA, KENICHI YOSHIMURA and HIROSHI KAWAMOTO
    Anticancer Research May 2023, 43 (5) 1919-1924; DOI: https://doi.org/10.21873/anticanres.16351
  • You have access
    C4orf47 Contributes to the Induction of Stem-like Properties in Gallbladder Cancer Under Hypoxia
    LIN NA, SHOGO MASUDA, SHINJIRO NAGAO, SHINJI MORISAKI, NAOYA IWAMOTO, KEITA SAKANASHI and HIDEYA ONISHI
    Anticancer Research May 2023, 43 (5) 1925-1932; DOI: https://doi.org/10.21873/anticanres.16352
  • You have access
    Synergistic and Antagonistic Antiproliferative Effects of Ribociclib (Lee011) and Irinotecan (SN38) on Colorectal Cancer Cells
    CHUNG-I HUANG, YI-KAI HUANG, HUI-MING LEE, JIAN-HAN CHEN, YU-CHIEH SU and PAI-MEI LIN
    Anticancer Research May 2023, 43 (5) 1933-1941; DOI: https://doi.org/10.21873/anticanres.16353
  • You have access
    ATG9B Is a Poor Prognostic Marker Associated With Immune Evasion in Colon Adenocarcinoma
    IN SOO KIM, SANG YEON CHO, MISO YANG, SONGYEON HAN, KYUNG-HA LEE, JI YEON KIM, JIN MAN KIM, SORA KANG, EUN-KYEONG JO and HYEWON RYU
    Anticancer Research May 2023, 43 (5) 1943-1957; DOI: https://doi.org/10.21873/anticanres.16354
  • You have access
    Anti-cancer Effect of Unique Cartilage Matrix-associated Protein in Breast Cancer Cells Depends on γ-Carboxylation
    NA RAE PARK, YEON-JU LEE, SEUNG-HOON LEE and JUNG-EUN KIM
    Anticancer Research May 2023, 43 (5) 1959-1965; DOI: https://doi.org/10.21873/anticanres.16355
  • You have access
    Comparison of the Characteristics of Two Types of Parallel-plate Ionization Chamber Under Small-field Electron Irradiation
    YUYA YANAGI, HAJIME MONZEN, KAZUKI KUBO, JUNKO SUGIYAMA, KAZUO NOMA, TAKAAKI ITO, YUSUKE SAKAI, KENJI NAKAMURA, TETSUO KIDA, HIROSHI DOI and YASUMASA NISHIMURA
    Anticancer Research May 2023, 43 (5) 1967-1972; DOI: https://doi.org/10.21873/anticanres.16356
  • You have access
    Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors
    YU JIN KIM, SE-KYEONG JANG, GYEONGMI KIM, SUNG-EUN HONG, CHAN SUB PARK, MIN-KI SEONG, HYUN-AH KIM, KWANG SEOK KIM, CHUN-HO KIM, KI SOO PARK, JUNGIL HONG, HYEON-OK JIN and IN-CHUL PARK
    Anticancer Research May 2023, 43 (5) 1973-1980; DOI: https://doi.org/10.21873/anticanres.16357
  • You have access
    Itraconazole Modulates Phospholipid Levels in Tumor-associated Macrophages
    YUMI TAKIMOTO, HIROSHI TSUBAMOTO, ROZE ISONO-TANIGUCHI, TOMOKO UEDA, KAZUKO SAKATA, KOHEI NAKAGAWA, SACHIYO NARITA, YU WAKIMOTO, HIROAKI SHIBAHARA and SHIN NISHIUMI
    Anticancer Research May 2023, 43 (5) 1981-1984; DOI: https://doi.org/10.21873/anticanres.16358
  • You have access
    TU-100 Antagonizes the M2 Polarization Phenotype of Macrophages in the Tumor Microenvironment by Suppressing the TLR4/NF-GraphicB/STAT3 Axis
    SHUHAI CHEN, YUJI MORINE, YU SAITO, SHINICHIRO YAMADA, HIROKI TERAOKU, TETSUYA IKEMOTO and MITSUO SHIMADA
    Anticancer Research May 2023, 43 (5) 1985-1992; DOI: https://doi.org/10.21873/anticanres.16359

Clinical Studies

  • Open Access
    A Phase I/II Investigation of Safety and Efficacy of Nivolumab and nab-Sirolimus in Patients With a Variety of Tumors With Genetic Mutations in the mTOR Pathway
    ERLINDA M. GORDON, NICOLE L. ANGEL, NADEZHDA OMELCHENKO, VICTORIA S. CHUA-ALCALA, ANIA MORADKHANI, DORIS QUON and STEVEN WONG
    Anticancer Research May 2023, 43 (5) 1993-2002; DOI: https://doi.org/10.21873/anticanres.16360
  • Open Access
    Long-term Outcomes After Moderate Hypofractionated Proton Therapy for Centrally Located Non-small Cell Lung Cancer
    MASATOSHI NAKAMURA, HITOSHI ISHIKAWA, KAYOKO OHNISHI, KEIICHIRO BABA, TAISUKE SUMIYA, MOTOHIRO MURAKAMI, YUICHI HIROSHIMA, MASASHI MIZUMOTO, TOSHIYUKI OKUMURA and HIDEYUKI SAKURAI
    Anticancer Research May 2023, 43 (5) 2003-2013; DOI: https://doi.org/10.21873/anticanres.16361
  • Open Access
    Prognostic Impact of Ras Mutation on Surgical Strategy in Rectal Cancer Patients Undergoing Neoadjuvant Treatment
    ELENA ORLANDI, ANDREA ROMBOLI, CHIARA CITTERIO, SERENA TRUBINI, STEFANO VECCHIA, MARIA ANGELA PALLADINO, PATRIZIO CAPELLI and LUIGI CAVANNA
    Anticancer Research May 2023, 43 (5) 2015-2024; DOI: https://doi.org/10.21873/anticanres.16362
  • You have access
    Nowarta110 Topical Versus Placebo for the Treatment of Plantar Warts: A Phase I/II Randomized Controlled Clinical Trial
    MAHKAMEH YOUSEFPOUR, IRAJ ZAMANIAN, FERRE AKBARPOUR, WILLIAM H. FANG, BO HAN and BA X. HOANG
    Anticancer Research May 2023, 43 (5) 2025-2030; DOI: https://doi.org/10.21873/anticanres.16363
  • Open Access
    Exploring the Patient Perspective of Bone Sarcoma Survivors Who Have Undergone Particle Radiotherapy Abroad
    LENA FAUSKE, NINA L. JEBSEN, HILDE BONDEVIK and ØYVIND S. BRULAND
    Anticancer Research May 2023, 43 (5) 2031-2039; DOI: https://doi.org/10.21873/anticanres.16364
  • You have access
    Helical Tomotherapy of Lymph Node-negative Early-stage Breast Cancer After Breast-conserving Surgery: Long-term Results
    FELIX ZWICKER, RUDOLF KLEPPER, HENRIK HAUSWALD, SEBASTIAN HOEFEL, LUIS RAETHER, PETER E. HUBER, JUERGEN DEBUS and MICHAEL SCHEMPP
    Anticancer Research May 2023, 43 (5) 2041-2053; DOI: https://doi.org/10.21873/anticanres.16365
  • You have access
    Survival Benefits of Laparoscopic Gastrectomy in Elderly Patients With Gastric Cancer: Focusing on Preoperative Nutritional and Inflammatory Status
    SHUHEI ITO, KIPPEI OHGAKI, TETSURO KAWAZOE, SHOTA SATO, SHUNJI IKEDA, KEISEI KAKIZOE, HUANLIN WANG, TOSHIHIKO NAKAMURA, SHINICHIRO MAEHARA, EISUKE ADACHI, YOICHI IKEDA and YOSHIHIKO MAEHARA
    Anticancer Research May 2023, 43 (5) 2055-2067; DOI: https://doi.org/10.21873/anticanres.16366
  • You have access
    Tumor DNA in Peritoneal Lavage as a Novel Biomarker for Predicting Peritoneal Recurrence in Patients With Gastric Cancer
    NORIO YUKAWA, TAKESHI YAMADA, TORU AOYAMA, TEKKAN WOO, KOJI UEDA, AKIHISA MASTUDA, KENTARO HARA, KEISUKE KAZAMA, HIROSHI TAMAGAWA, TSUTOMU SATO, TAKASHI OSHIMA, AKIHIRO SUZUKI, HIROYUKI ABURATANI, SHUMPEI ISHIKAWA, AYA SAITO, MUNETAKA MASUDA, HIROSHI YOSHIDA and YASUSHI RINO
    Anticancer Research May 2023, 43 (5) 2069-2076; DOI: https://doi.org/10.21873/anticanres.16367
  • Open Access
    CD8-positive Tumor-infiltrating Lymphocytes and Prognosis in Radiotherapy for Uterine Cervical Squamous Cell Carcinoma
    YUHEI MIYASAKA, YUYA YOSHIMOTO, KEN ANDO, KAZUTOSHI MURATA, DAISUKE IRIE, HIRO SATO, SHIN-EI NODA, HAYATO IKOTA, TAKASHI NAKANO, HIDEAKI YOKOO and TATSUYA OHNO
    Anticancer Research May 2023, 43 (5) 2077-2084; DOI: https://doi.org/10.21873/anticanres.16368
  • Open Access
    Relationship Between Safety and Cumulative Bevacizumab Dose in Patients With Metastatic Colorectal Cancer Who Received Long-term Bevacizumab Treatment
    SATOSHI FUKUDA, YUSUKE NIISATO, MIKI TSUJI, SOMA FUKUDA, YUYA HAGIWARA, TSUBASA ONODA, HIROSUMI SUZUKI, YOSHITAKA TANGE, TAKESHI YAMADA, YOSHIYUKI YAMAMOTO and TOSHIKAZU MORIWAKI
    Anticancer Research May 2023, 43 (5) 2085-2090; DOI: https://doi.org/10.21873/anticanres.16369
  • You have access
    Comprehensive Genomic Profiling Detects Hereditary Cancers and Confers Survival Advantage in Patients With Gynaecological Cancers
    TOMOKO UEDA, HIROSHI TSUBAMOTO, YUMI TAKIMOTO, ROZE ISONO-TANIGUCHI, SACHIYO NARITA, KOHEI NAKAGAWA, YU WAKIMOTO, YUMIKO NISHIMURA, YOSHIKO MUROI, MASAYUKI NAGAHASHI, SEIICHI HIROTA, HIDEAKI SAWAI and HIROAKI SHIBAHARA
    Anticancer Research May 2023, 43 (5) 2091-2101; DOI: https://doi.org/10.21873/anticanres.16370
  • Open Access
    Prevalence and Risk Factors of Emotional Distress in Patients With Prostate Cancer Assigned to External-beam Radiotherapy With or Without High-dose Rate Brachytherapy
    AHMED AL-SALOOL, TAMER SOROR, NATHAN Y. YU and DIRK RADES
    Anticancer Research May 2023, 43 (5) 2103-2109; DOI: https://doi.org/10.21873/anticanres.16371
  • Open Access
    Prevalence of and Risk Factors for Emotional Distress in Patients Undergoing Radiotherapy for Lung Cancer
    DIRK RADES, AHMED AL-SALOOL, SABINE BOHNET and NATHAN Y. YU
    Anticancer Research May 2023, 43 (5) 2111-2118; DOI: https://doi.org/10.21873/anticanres.16372
  • You have access
    Efficacy and Tolerability of Second-line Pembrolizumab With Radiation Therapy in Advanced Urothelial Carcinoma
    TAKESHI SANO, RIHITO AIZAWA, KATSUHIRO ITO, KIYONAO NAKAMURA, TAKASHI OGATA, MASASHI TAKEDA, AKIHIRO HAMADA, TAKASHI MATSUOKA, JIN KONO, YUKI KITA, KIMIHIKO MASUI, TAKAYUKI GOTO, ATSURO SAWADA, SHUSUKE AKAMATSU, OSAMU OGAWA, TAKASHI MIZOWAKI and TAKASHI KOBAYASHI
    Anticancer Research May 2023, 43 (5) 2119-2126; DOI: https://doi.org/10.21873/anticanres.16373
  • Open Access
    Clinical Benefits of LigaSure™ for Surgical Amputation Without Tourniquet Use in Patients With Musculoskeletal Tumor
    MARTIN LOUIE S. BANGCOY, SHINJI MIWA, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, KENTARO IGARASHI, YUTA TANIGUCHI, SEI MORINAGA, YOHEI ASANO and HIROYUKI TSUCHIYA
    Anticancer Research May 2023, 43 (5) 2127-2133; DOI: https://doi.org/10.21873/anticanres.16374
  • You have access
    Vacuum-assisted Evacuation (VAEv) of Symptomatic and/or Voluminous Breast Haematomas Following Surgeries and Percutaneous Procedures
    ROSARIA MEUCCI, ORESTE CLAUDIO BUONOMO, TOMMASO PERRETTA, GUGLIELMO MANENTI, GIANLUCA VANNI, ELEONORA LOMBARDO, MARIA LINA SERIO, FRANCESCA DI PIETRO, MARCO PELLICCIARO, FRANCESCA MONTESANTO, CHIARA PALOMBI, FLAVIA RUFI, MARCO MATERAZZO and CHIARA ADRIANA PISTOLESE
    Anticancer Research May 2023, 43 (5) 2135-2143; DOI: https://doi.org/10.21873/anticanres.16375
  • You have access
    Clinical Significance of Cancer Stem Cell Markers in Primary and Metastatic Tissues in Patients With Breast Cancer
    TAKASHI YAMANAKA, TAKASHI OSHIMA, DAISUKE MURAYAMA, SAKI OKAMOTO, AI MATSUI, MIO YASUKAWA, YUKA MATSUBARA, SOJI TODA, YUKIHIKO HIROSHIMA, TORU AOYAMA, NOBUYASU SUGANUMA, YASUSHI RINO, AYA SAITO, YOHEI MIYAGI, HIROYUKI IWASAKI and TOSHINARI YAMASHITA
    Anticancer Research May 2023, 43 (5) 2145-2154; DOI: https://doi.org/10.21873/anticanres.16376
  • You have access
    Moderately Hypofractionated Radio(chemo)therapy With Simultaneous Integrated Boost for Recurrent, Previously Irradiated, High-grade Glioma
    PASCAL GRAEN, HANS CHRISTIANSEN, MANOLIS POLEMIKOS, CONSTANTIN HEETFELD, FRIEDRICH FEUERHAKE, BETTINA WIESE and ROLAND MERTEN
    Anticancer Research May 2023, 43 (5) 2155-2160; DOI: https://doi.org/10.21873/anticanres.16377
  • You have access
    Reducing the Use of Frozen Section for Sentinel Node Biopsy in Breast Carcinoma: Feasibility and Outcome
    TOMMASO SUSINI, ILARIA NESI, IRENE RENDA, MILO GIANI, JACOPO NORI, ERMANNO VANZI and SIMONETTA BIANCHI
    Anticancer Research May 2023, 43 (5) 2161-2170; DOI: https://doi.org/10.21873/anticanres.16378
  • You have access
    Dorsal Subcutaneous Fat Thickness as a Risk Factor for Pancreatic Fistula After Gastric Cancer Surgery
    HIRONARI MIYAMOTO, MAMI YOSHII, HIROAKI TANAKA, SATOSHI NISHI, SOTA DEGUCHI, YUICHIRO MIKI, TATSURO TAMURA, TAKAHIRO TOYOKAWA, SHIGERU LEE and KIYOSHI MAEDA
    Anticancer Research May 2023, 43 (5) 2171-2178; DOI: https://doi.org/10.21873/anticanres.16379
  • You have access
    New Scale Predicting Distant Recurrence in Locally Advanced Lower Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy
    RYOSUKE NAKAGAWA, TSUTOMU KUMAMOTO, FUMI MAEDA, KIMITAKA TANI, HIROKA KONDO, KURODO KOSHINO, YUKA KANEKO, YOSHIKO BAMBA, SHIMPEI OGAWA, YUJI INOUE, MICHIO ITABASHI and SHIGEKI YAMAGUCHI
    Anticancer Research May 2023, 43 (5) 2179-2184; DOI: https://doi.org/10.21873/anticanres.16380
  • You have access
    Influence of Smoking History on the Effectiveness of Immune-checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer: Analysis of Real-world Data
    KENJI NAKAHAMA, MOTOHIRO IZUMI, NAOKI YOSHIMOTO, MITSURU FUKUI, AKIRA SUGIMOTO, HIROAKI NAGAMINE, KOICHI OGAWA, KENJI SAWA, YOKO TANI, HIROYASU KANEDA, SHIGEKI MITSUOKA, TETSUYA WATANABE, KAZUHISA ASAI and TOMOYA KAWAGUCHI
    Anticancer Research May 2023, 43 (5) 2185-2197; DOI: https://doi.org/10.21873/anticanres.16381
  • You have access
    The Suppressive Effect of NF-kB Activation After Eicosapentaenoic Acid Intake Before Surgery
    HISAKO KUBOTA, TOSHIHIRO HIRAI, AYAKO OGO, HIDEO MATSUMOTO, MASAHARU HIGASHIDA, SHUNJI ENDO, YOSHINORI FUJIWARA and TOMIO UENO
    Anticancer Research May 2023, 43 (5) 2199-2202; DOI: https://doi.org/10.21873/anticanres.16382
  • You have access
    Clinical Impact of Laparoscopic Surgery on the Long-term Survival of Advanced Gastric Cancer Patients With Regard to Facilitating Doublet Adjuvant Chemotherapy
    KOSHIRO MORINO, MICHIHIRO YAMAMOTO, RYOSUKE YAMANAKA, YUTA IWASAKI, NOZOMU NAKANISHI, TOSHIHIKO GOTO, HIROKAZU TANAKA, RYO MATSUSUE and TAKAFUMI MACHIMOTO
    Anticancer Research May 2023, 43 (5) 2203-2209; DOI: https://doi.org/10.21873/anticanres.16383
  • You have access
    Transanal Total Mesorectal Excision for Extended Surgery in the Early Stage After Introduction
    SHUNJIN RYU, TAKAHIRO KITAGAWA, KEISUKE GOTO, ATSUSHI NAGASHIMA, TAKEHIRO KOBAYASHI, JUNICHI SHIMADA, RYUSUKE ITO and YUKIO NAKABAYASHI
    Anticancer Research May 2023, 43 (5) 2211-2217; DOI: https://doi.org/10.21873/anticanres.16384
  • You have access
    N2 Lymph Node Metastasis Is a Useful Predictor of Recurrence in Patients With Stage III Rectal Cancer Undergoing Adjuvant Chemotherapy Using Tegafur–uracil/leucovorin
    SHOTARO MIYASHITA, TAKAYUKI SHIMIZU, MITSURU ISHIZUKA, MAIKO NIKI, YUSUKE NISHI, NORISUKE SHIBUYA, HIROYUKI HACHIYA, TAKATSUGU MATSUMOTO, YUHKI SAKURAOKA, TAKAYUKI SHIRAKI, SHOZO MORI, YUKIHIRO ISO, ATSUSHI IRISAWA and TAKU AOKI
    Anticancer Research May 2023, 43 (5) 2219-2225; DOI: https://doi.org/10.21873/anticanres.16385
  • You have access
    Emotional Distress in Head-and-neck Cancer Patients Scheduled for Chemoradiation or Radiotherapy Alone
    AHMED AL-SALOOL, TAMER SOROR, NATHAN Y. YU, CHRISTIAN IDEL, KARL L. BRUCHHAGE, SAMER G. HAKIM and DIRK RADES
    Anticancer Research May 2023, 43 (5) 2227-2233; DOI: https://doi.org/10.21873/anticanres.16386
  • You have access
    Breast Cancer and SARS-Cov2: Lessons from a Pandemic
    MARIE GOSSET, JOCELYN GAL, RENAUD SCHIAPPA, CHRISTOPHER HELWIG, IRIS BONOMO, YANN DELPECH and EMMANUEL BARRANGER
    Anticancer Research May 2023, 43 (5) 2235-2241; DOI: https://doi.org/10.21873/anticanres.16387
  • You have access
    Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study ‘LUNGFUL’
    GIANNIS MOUNTZIOS, ANNA KOUMARIANOU, HELENA LINARDOU, ANASTASIOS BOUTIS, DIMITRIOS MAVROUDIS, EPAMINONDAS SAMANTAS, IPPOKRATIS KORANTZIS, ELIAS ATHANASIADIS, EVANGELOS G. FERGADIS, SOFIA LAMPAKI, VASSILIS GEORGOULIAS, SOFIA BAKA, MICHALIS V. KARAMOUZIS, IOANNIS BOUKOVINAS, CHARALAMPOS ANDREADIS, AGGELIKI RAPTI, NIKOLAOS KOULOURIS, GEORGE PENTHEROUDAKIS, MARIOS E. FROUDARAKIS, ALVERTOS SOMARAKIS, ELEFTHERIA ANASTASOPOULOU, ALEXANDRA KARADIMOU, FOTEINI PAPAGEORGIOU, ZOE PAPAREPA, ARISTEIDIS NIKOLAOU, CHRISTINA PAPISTA and KONSTANTINOS N. SYRIGOS
    Anticancer Research May 2023, 43 (5) 2243-2258; DOI: https://doi.org/10.21873/anticanres.16388
  • You have access
    In Vivo Dosimetry in the Urethra During Prostate Carbon Ion Radiotherapy
    SHINNOSUKE MATSUMOTO, NARUHIRO MATSUFUJI, YUSUKE KOBA and HIROSHI TSUJI
    Anticancer Research May 2023, 43 (5) 2259-2264; DOI: https://doi.org/10.21873/anticanres.16389
  • You have access
    Effectiveness of Spacers in Brachytherapy With 198Au Grains for Patients With Buccal Mucosa Cancer
    MASARU KONISHI, JUNICHI HIROKAWA, SHOTA MIYOSHI, TSUYOSHI KATSUTA, NOBUKI IMANO, IKUNO NISHIBUCHI, YUJI MURAKAMI, KIICHI SHIMABUKURO, TAKEO NAKASHIMA, YUKI TAKEUCHI, NAOYA KAKIMOTO and YASUSHI NAGATA
    Anticancer Research May 2023, 43 (5) 2265-2271; DOI: https://doi.org/10.21873/anticanres.16390
  • You have access
    Laparoscopic Liver Resection Procedure Attenuates Organ-space Surgical Site Infection Compared With Open Procedure: A Propensity Score-matched Analysis
    KENICHIRO ARAKI, NORIFUMI HARIMOTO, AKIRA WATANABE, MARIKO TSUKAGOSHI, NORIHIRO ISHII, KEI HAGIWARA, RYO MURANUSHI, KOUKI HOSHINO, TAKAOMI SEKI and KEN SHIRABE
    Anticancer Research May 2023, 43 (5) 2273-2280; DOI: https://doi.org/10.21873/anticanres.16391
  • You have access
    Epithelial-mesenchymal Transition Factor and Its Association With Mammographic Density and Breast Cancer Prognosis
    EUN YOUNG KIM and SANGJEONG AHN
    Anticancer Research May 2023, 43 (5) 2281-2292; DOI: https://doi.org/10.21873/anticanres.16392
  • You have access
    Efficacy and Cost-effectiveness of Pegfilgrastim for Preventing Febrile Neutropenia During Docetaxel, Cisplatin, and 5-Fluorouracil Therapy for Esophageal Cancer
    TAKANORI KUROGOCHI, AKIRA MATSUMOTO, YUYA NYUMURA, YUICHIRO TANISHIMA, TOMOKO NAKAYOSHI, TOMOYOSHI OKAMOTO, FUMIAKI YANO and KEN ETO
    Anticancer Research May 2023, 43 (5) 2293-2298; DOI: https://doi.org/10.21873/anticanres.16393
  • You have access
    Prognostic Impact of Malnutrition Diagnosed by the GLIM Criteria for Resected Extrahepatic Cholangiocarcinoma
    YUKI OKAZOE, HIROAKI YANAGIMOTO, DAISUKE TSUGAWA, MASAYUKI AKITA, RIKI ASAKURA, SATOSHI OMIYA, TAKESHI URADE, YOSHIHIDE NANNO, KENJI FUKUSHIMA, HIDETOSHI GON, SHOHEI KOMATSU, KAORI KURAMITSU, TADAHIRO GOTO, SADAKI ASARI, HIROCHIKA TOYAMA, MASAHIRO KIDO, TETSUO AJIKI and TAKUMI FUKUMOTO
    Anticancer Research May 2023, 43 (5) 2299-2308; DOI: https://doi.org/10.21873/anticanres.16394
  • You have access
    Poor Renal Function and a High Modified Glasgow Prognostic Score Are Predictive Factors for Nedaplatin/5-Fluorouracil Combination Therapy-induced Febrile Neutropenia
    JUNYA HASHIZUME, MADOKA NAMBU, HIROO NAKAGAWA, HITOMI HARASAWA and YUKINOBU KODAMA
    Anticancer Research May 2023, 43 (5) 2309-2316; DOI: https://doi.org/10.21873/anticanres.16395
  • You have access
    Does Multidisciplinary Therapy at a Sarcoma Center Improve the Prognosis of Patients With Soft Tissue Sarcoma? A Retrospective Case Study at a Single Institute
    TSUKASA YONEMOTO, HIROTO KAMODA, YOKO HAGIWARA and HIDEYUKI KINOSHITA
    Anticancer Research May 2023, 43 (5) 2317-2321; DOI: https://doi.org/10.21873/anticanres.16396
  • You have access
    Clinicopathological Significance and Predictive Value of High Intratumoral Tumor Budding in Patients With Breast Carcinoma Treated With Neoadjuvant Chemotherapy
    JINAH CHU, HYUN-SOO KIM and SUNG-IM DO
    Anticancer Research May 2023, 43 (5) 2323-2332; DOI: https://doi.org/10.21873/anticanres.16397
  • You have access
    Elevated Preoperative Serum Vascular Endothelial Growth Factor Does Not Predict Poor Outcomes in Curatively Resected Non-metastatic Colorectal Cancer Treated Without Neoadjuvant Therapy
    NOZOMU NAKAI, ANRI MAEDA, TAKESHI YANAGITA, TAKUYA SUZUKI, YUZO MAEDA, TAKAHISA HIROKAWA, KAZUYOSHI SHIGA, MASAYASU HARA, HIROKI TAKAHASHI, RYO OGAWA, YOICHI MATSUO and SHUJI TAKIGUCHI
    Anticancer Research May 2023, 43 (5) 2333-2341; DOI: https://doi.org/10.21873/anticanres.16398
  • You have access
    Dual Biomarker Combining DNA Damage Repair Gene Mutations and PD-L1 Expression for Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    HYERA KIM, DONG HYUN LIM, YONG SHIK KWON, MI AE KIM and KEON UK PARK
    Anticancer Research May 2023, 43 (5) 2343-2349; DOI: https://doi.org/10.21873/anticanres.16399
  • You have access
    Emetogenicity and Risk Factors of Nausea and Vomiting in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil and Bevacizumab Chemotherapy
    SERIKA MATSUOKA, HIRONORI FUJII, HIROTOSHI IIHARA, KOICHI OHATA, CHIEMI HIROSE, DAICHI WATANABE, SHIORI SADAKA, SHIGERU KIYAMA, AKITAKA MAKIYAMA, TAKAO TAKAHASHI, RYO KOBAYASHI, NOBUHISA MATSUHASHI and AKIO SUZUKI
    Anticancer Research May 2023, 43 (5) 2351-2357; DOI: https://doi.org/10.21873/anticanres.16400
  • Open Access
    Liver Metastases of Unknown Primary Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors: A Case Report and Literature Review
    DAVIDE BIMBATTI, NICOLÒ CAVASIN, FRANCESCA GALUPPINI, ALESSANDRO RAGO, GAETANO RAMONDO, ELEONORA LAI, MICHELE DIONESE, ELISA ERBETTA, UMBERTO BASSO and MARCO MARUZZO
    Anticancer Research May 2023, 43 (5) 2359-2365; DOI: https://doi.org/10.21873/anticanres.16401
  • You have access
    Metastatic Adenocarcinoma of the Lung Presenting as a Presternal Cutaneous Mass: Case Report and Brief Literature Review
    HASNA KERROUCH, MARIE DANSET, NAOUFAL HJIRA and JEAN KANITAKIS
    Anticancer Research May 2023, 43 (5) 2367-2370; DOI: https://doi.org/10.21873/anticanres.16402
  • You have access
    Successful Prevention of Tumour Lysis Syndrome in HER2-positive Breast Cancer: Case Report and Literature Review
    SACHIE OMORI, TOMOKO SHIGECHI, KANA KAWAGUCHI, HIDEKI IJICHI, EIJI OKI and TOMOHARU YOSHIZUMI
    Anticancer Research May 2023, 43 (5) 2371-2377; DOI: https://doi.org/10.21873/anticanres.16403

Addendum

  • Open Access
    ADDENDUM to:
    Anticancer Research May 2023, 43 (5) 2379; DOI: https://doi.org/10.21873/anticanres.16404

Corrigendum

  • Open Access
    Corrigendum
    Anticancer Research May 2023, 43 (5) 2381; DOI: https://doi.org/10.21873/anticanres.16405
Back to top
PreviousNext

In this issue

Anticancer Research: 43 (5)
Anticancer Research
Vol. 43, Issue 5
May 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • The Novel Use of IL-28 as an Effective Radiosensitizer in Pancreatic Cancer
  • Somatic Variants in DNA Damage Response Genes in Ovarian Cancer Patients Using Whole-exome Sequencing
  • Dimethyl Fumarate Suppresses the Proliferation of HTLV-1-infected T Cells by Inhibiting CBM Complex-triggered NF-GraphicB Signaling
  • Reinforcement of the Tumor Suppressing Properties of microRNA-1 by Substitution at the C2′ Position of Varying Ribose Residues in Chemically Synthesized microRNA-1 Molecules
  • A Phase I/II Investigation of Safety and Efficacy of Nivolumab and nab-Sirolimus in Patients With a Variety of Tumors With Genetic Mutations in the mTOR Pathway
Sign up for alerts

Jump to

  • Review
  • Experimental Studies
  • Clinical Studies
  • Addendum
  • Corrigendum
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire